Treating the Diseased Superficial Femoral Artery

Techniques in Vascular and Interventional Radiology

Volumn 13, Issue 1, 2010, Pages 37-42

  Gibbs, Jerry M ^a   Peña, Constantino S ^b   Benenati, James F ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

Author keywords

claudication; peripheral vascular disease; superficial femoral artery

Indexed keywords

ANGIOPLASTY; ARTERY DISEASE; DRUG ELUTING STENT; FEMORAL ARTERY; HUMAN; LIMB ISCHEMIA; REVIEW; VASCULAR DISEASE; VASCULAR LESION;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; EMBOLISM; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; MALE; MIDDLE AGED; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASES; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME;

EID: 72149113850     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2009.10.005     Document Type: Review

References (20)

1. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 suppl S (2007) S5-S67
2. Hertzer N.R. The natural history of peripheral vascular disease. Implications for its management. Circulation 83 suppl (1991) I12-I19
3. Cox G.S., Hertzer N.R., Young J.R., et al. Nonoperative treatment of superficial femoral artery disease: Long term follow up. J Vasc Surg 17 (1993) 172-181 discussion 181-182
4. Spronk S., Bosch J.L., den Hoed P.T., et al. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: A randomized control trial. J Vasc Surg 48 (2008) 1472-1480
5. Taylor S.M., Kalbaugh C.A., Healy M.G., et al. Do current outcomes justify more liberal use of revascularization for vasculogenic claudication?. A single center experience of 1,000 conservatively treated limbs. J Am Coll Surg 206 (2008) 1053-1062 discussion 1062-1064
6. Rocha-Singh K., Jaff M.R., Crabtree T.R., et al. Performance goals and end point assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 69 (2007) 910-919
7. Powell R.J. Endovascular treatment in the superficial femoral artery: Which devices, where?. Semin Vasc Surg 21 (2008) 180-185
8. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
9. Schillinger M., Sabeti S., Dick P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007) 2745-2749
10. Katzen BT: The RESILIENT trial: Evidence for SFA stenting. Paper presented at: The British Society of Interventional Radiology Annual Meeting, 2009; Manchester Central, UK
11. Duda S.H., Puisch B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six month results. Circulation 106 (2002) 1505-1509
12. Duda S.H., Bosiers M., Lammer J., et al. Sirolimas-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J Vasc Interv Radiol 16 (2005) 331-338
13. Saxon R.R., Dake M.D., Volgelzang R.L., et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19 (2008) 823-832
14. Kedora J., Hohmann S., and Garrett W. Randomized comparison of percutaneous Viabahn stent grafts versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 45 (2007) 10-16
15. Mewissen MW. VIBRANT single center and multicenter results (VIBRANT trial) of viabahn stent-graft vs. uncovered nitinol stent for SFA occlusive disease. Paper presented at: The VEITH Symposium; November 20, 2008; New York, NY
16. Bosiers M: MELOPEE-study: 12 month data-clinical duplex and Xray outcome of the lifestent in popliteal lesions. Paper presented at the International Symposium on Endovascular Therapy Annual Meet; January 22, 2008; Hollywood, FL
17. Duda S.H., Bosiers M., Lammer J., et al. Drug-eluting and bare nitinol stents for treatment of atherosclerotic lesions in the superficial femoral artery: Long term results form the SIROCCO trial. J Endovasc Ther 13 (2006) 701-710
18. Siablis D., Kamabatidis D., Katsanos K., et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: Enduring 1-year angiographic and clinical benefit. J Endovasc Ther 14 (2007) 241-250
19. Siablis D., Kamabatidis D., Katsanos K., et al. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: Midterm angiographic and clinical results. J Vasc Interv Radiol 18 (2007) 1351-1361
20. Karnabatidis D., Katsanos K., Kagadis G.C., et al. Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: An underestimated phenomenon. J Endovasc Ther 13 (2006) 269-280